Unique ID issued by UMIN | UMIN000010266 |
---|---|
Receipt number | R000012017 |
Scientific Title | Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients. |
Date of disclosure of the study information | 2013/03/18 |
Last modified on | 2016/03/08 09:49:46 |
Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients.
Aimix study
Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients.
Aimix study
Japan |
Hypertension with type 2 diabetes
Endocrinology and Metabolism |
Others
NO
Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients.
Safety,Efficacy
Change of the blood pressure on medical examination
Urinary albumin
Serum creatinine
eGFR
Serum uric acid
Serum potassium
HbA1c
Pntraxin3
Interventional
Single arm
Non-randomized
Open -no one is blinded
Active
1
Treatment
Medicine |
Switching ABR and CCB, which patients are already taking, to irbesartan/amlodipine single-pill combination drug. Other anti-hypertensive and anti-diabetic medications are maintained at the same dosage throughout the study.
20 | years-old | <= |
Not applicable |
Male and Female
The inclusion criteria are a baseline systolic blood pressure ≥130 or diastolic blood pressure ≥80 mmHg on medical examination in the patients who are taking antihypertensive agents, including ARB and CCB for more than one month.
The exclusion criteria are based on fulfillment of at least one of the following; 1) a past history of allergy of this medicine or dihydropyridine drugs; 2) pregnancy, possibility of pregnancy; 3) current treatment with corticosteroids and/or immnosuppressive drugs; 4) patients who judge that the physician is not suitable
50
1st name | |
Middle name | |
Last name | Daisuke Koya |
Kanazawa Medical University Hospital
Endocrinology and Metabolism
Daigaku1-1 Uchinadamachi Kahokugun Ishikaw
1st name | |
Middle name | |
Last name |
Kanazawa Medical University Hospital
Endocrinology and Metabolism
Daigaku1-1 Uchinadamachi Kahokugun Ishikawa
Kanazawa Medical University
Diabetes and Endocrinology
Kanazawa Medical University
Diabetes and Endocrinology
Self funding
NO
2013 | Year | 03 | Month | 18 | Day |
Unpublished
Completed
2013 | Year | 01 | Month | 22 | Day |
2013 | Year | 03 | Month | 06 | Day |
2013 | Year | 03 | Month | 18 | Day |
2016 | Year | 03 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012017
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |